Remove Dermatology Remove Doctors Remove Marketing Remove Pharma Companies
article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

And this year Eli Lilly stepped into the obesity drug market with its own GLP-1 weight loss drug Zepbound (tirzepatide), which the US Food and Drug Administration (FDA) approved in November of this year. Check out this article to learn about the biotech companies that went public this year.

article thumbnail

How digital pathways are changing healthcare

pharmaphorum

Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. There’s an enormous market for similar approaches in other disease areas. “In As demonstrated throughout COVID, digital health is no longer experimental.

Doctors 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52